Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

Biotechnology

Health Care

Therapeutics

Valo Therapeutics

Paul G Higham

Philip Stanecki

Matthew Vaughan

Paul Porter

Otto Kari

Petri Priha

Sari Pesonen

The Scientific and Research Team at Valo Therapeutics focuses on developing innovative immunooncology therapies by engineering tumour antigen-coated oncolytic viruses. The team conducts advanced research, validates antigen targets, and manages laboratory operations to translate scientific findings into effective therapeutic vaccines.

Scientific and Research Team

Leadership Team

Clinical and Regulatory Team

Scientific and Research Team

About

Team members

Other teams at Valo Therapeutics

Leadership Team

Clinical and Regulatory Team